tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ADAP Stock Latest News

Hold Rating for Adaptimmune Therapeutics Amid Strategic Progress and Financial Uncertainties
RatingsHold Rating for Adaptimmune Therapeutics Amid Strategic Progress and Financial Uncertainties
2d ago
ADAP
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2d ago
INM
XLO
Adaptimmune’s Earnings Call: Success Amid Financial Concerns
PremiumCompany Announcements
Adaptimmune’s Earnings Call: Success Amid Financial Concerns
3d ago
ADAP
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3d ago
BMY
ABBV
Cautious Hold on Adaptimmune Therapeutics Amid Strategic Developments and Liquidity Concerns
PremiumRatings
Cautious Hold on Adaptimmune Therapeutics Amid Strategic Developments and Liquidity Concerns
4d ago
ADAP
Promising Growth Prospects and Strategic Advancements Drive Buy Rating for Adaptimmune Therapeutics
PremiumRatingsPromising Growth Prospects and Strategic Advancements Drive Buy Rating for Adaptimmune Therapeutics
4d ago
ADAP
Adaptimmune price target lowered to $1 from $1.50 at Wells Fargo
Premium
The Fly
Adaptimmune price target lowered to $1 from $1.50 at Wells Fargo
4d ago
ADAP
Adaptimmune price target lowered to 46c from $1 at Barclays
Premium
The Fly
Adaptimmune price target lowered to 46c from $1 at Barclays
5d ago
ADAP
Adaptimmune Therapeutics Reports Q1 2025 Earnings
PremiumCompany Announcements
Adaptimmune Therapeutics Reports Q1 2025 Earnings
5d ago
ADAP
ADAP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ADAP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8d ago
ADAP
Adaptimmune Therapeutics CFO Departure Terms Revised
PremiumCompany Announcements
Adaptimmune Therapeutics CFO Departure Terms Revised
1M ago
8K
ADAP
Adaptimmune downgraded to Hold from Buy at JonesResearch
PremiumThe Fly
Adaptimmune downgraded to Hold from Buy at JonesResearch
1M ago
ADAP
Adaptimmune Therapeutics: Hold Rating Amid Financial Uncertainties and Strategic Challenges
PremiumRatingsAdaptimmune Therapeutics: Hold Rating Amid Financial Uncertainties and Strategic Challenges
1M ago
ADAP
Adaptimmune price target lowered to $3 from $3.50 at H.C. Wainwright
Premium
The Fly
Adaptimmune price target lowered to $3 from $3.50 at H.C. Wainwright
2M ago
ADAP
Adaptimmune Therapeutics: Balancing Positive Momentum with Strategic Pauses – A Hold Rating Analysis
Premium
Ratings
Adaptimmune Therapeutics: Balancing Positive Momentum with Strategic Pauses – A Hold Rating Analysis
2M ago
ADAP
Adaptimmune price target lowered to $1.75 from $3 at Guggenheim
PremiumThe Fly
Adaptimmune price target lowered to $1.75 from $3 at Guggenheim
2M ago
ADAP
Adaptimmune’s Earnings Call: TECELRA Success and Future Outlook
PremiumCompany Announcements
Adaptimmune’s Earnings Call: TECELRA Success and Future Outlook
2M ago
ADAP
Adaptimmune price target lowered to $1.40 from $3.15 at Scotiabank
PremiumThe Fly
Adaptimmune price target lowered to $1.40 from $3.15 at Scotiabank
2M ago
ADAP
Adaptimmune price target lowered to $1.50 from $2 at Wells Fargo
PremiumThe Fly
Adaptimmune price target lowered to $1.50 from $2 at Wells Fargo
2M ago
ADAP
Adaptimmune’s Strategic Moves in Cancer Therapy
PremiumCompany AnnouncementsAdaptimmune’s Strategic Moves in Cancer Therapy
2M ago
ADAP
Adaptimmune Therapeutics Reports Q4 2024 Business Update
Premium
Company Announcements
Adaptimmune Therapeutics Reports Q4 2024 Business Update
2M ago
8K
ADAP
Is ADAP a Buy, Before Earnings?
Premium
Pre-Earnings
Is ADAP a Buy, Before Earnings?
3M ago
ADAP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >